Opportunity Analysis of H1N1 (swine flu) Vaccination Market

Table of Contents

EXECUTIVE SUMMARY

• MARKET OVERVIEW
• GLOBAL H1N1 2009 INFLUENZA VACCINE MARKET, BY PRODUCTS
• GLOBAL H1N1 2009 INFLUENZA VACCINE MARKET, BY GEOGRAPHY
• COMPETITIVE SCENARIO

1. INTRODUCTION

• KEY TAKE-AWAYS
• REPORT DESCRIPTION
• SCOPE AND FORMAT
• STAKEHOLDERS

2. SUMMARY

• RESEARCH METHODOLOGY

3. MARKET OVERVIEW

• 1918 SPANISH INFLUENZA (H1N1) PANDEMIC
• 1957 - ASIAN FLU (H2N2)
• 1968 - HONGKONG FLU
• 2009 H1N1 INFLUENZA
  • H1N1 PANDEMIC CYCLE

4. MARKET DYNAMICS

• DRIVERS & RESTRAINTS
  • COST OF H1N1 VACCINE
  • VACCINE AWARENESS
  • SIDE-EFFECTS OF VACCINE
  • AVAILABILITY OF SUBSTITUTE TREATMENT
• MARKET FORCES ANALYSIS
  • SUPPLY-SIDE DRIVERS
  • DEMAND-SIDE DRIVERS
  • RESTRAINTS & OPPORTUNITIES
• PRICING OF H1N1 VACCINE
• CONSUMER INSIGHTS

5. GLOBAL H1N1 2009 INFLUENZA VACCINE MARKET

• MARKET OVERVIEW
  • PRIORITY GROUPS FOR THE H1N1 VACCINE
• DRIVERS & RESTRAINTS
  • PUBLIC-PRIVATE PARTNERSHIPS FOR SUPPLY OF H1N1 VACCINE
  • GOVERNMENT SUBSIDIES FOR VACCINE MANUFACTURE
  • REVENUE-INCREASING SOURCE
  • HIGH COSTS & LENGTHY MANUFACTURING PROCESS
• OPPORTUNITIES
  • SHIFT FROM EGG-BASED TO CELL-BASED MANUFACTURING
  • MARKET FOR ADJUVANTS
  • OPPORTUNITY FOR EMERGING ECONOMIES
• MANUFACTURING PROCESS OF INFLUENZA VACCINES
  • EGG-BASED MANUFACTURING
  • CELL-BASED MANUFACTURING
  • RECOMBINANT TECHNOLOGY
• INTRAMUSCULAR H1N1 VACCINE MARKET
  • DRIVERS & RESTRAINTS
    • Caters to large population segment
    • Rates low on user-friendliness
• INTRANASAL H1N1 VACCINE
  • DRIVERS & RESTRAINTS
    • User-friendly administration
    • Fewer side-effects & improved efficacy
    • Insurance coverage
    • Limited consumer segment
  • COMPETITIVE ANALYSIS
• BENCHMARKING OF APPROVED VACCINE
  • PIPELINE OVERVIEW OF H1N1 VACCINE

6. GEOGRAPHICAL ANALYSIS OF GLOBAL H1N1 VACCINE MARKET

• MOON MATRIX ANALYSIS OF GLOBAL 2009 H1N1 INFLUENZA VACCINE, BY GEOGRAPHY
  • HEALTHCARE EXPENDITURE & GOVERNMENT CONTRACTS
  • SPREAD OF H1N1 & AVAILABILITY OF H1N1 VACCINE
• NORTH AMERICAN H1N1 VACCINE MARKET
  • DRIVERS & RESTRAINTS
• EUROPE H1N1 VACCINE MARKET
  • DRIVERS & RESTRAINTS
• ASIA PACIFIC H1N1 VACCINE MARKET
  • AUSTRALIA
  • CHINA.
  • JAPAN.
  • INDIA
• REST OF WORLD (ROW) H1N1 VACCINE MARKET

7. STRATEGIC CONCLUSION

8. COMPANY PROFILES

• BAXTER INTERNATIONAL INC
• BUTANTAN INSTITUTE
• CANTACUZINO INSTITUTE OF SERA AND VACCINES
• CHANGCHUN INSTITUTE OF BIOLOGICAL PRODUCTS
• CRUCELL N.V.
• CSL
• DENKA SEIKEN CO LTD
• GREEN CROSS CORP
• GLAXOSMITHKLINE PLC
• HUALAN BIOLOGICAL ENGINEERING INC
• INOVIO BIOMEDICAL CORP
• KITASATO INSTITUTE
• MEDIMMUNE
• MERCK & CO
• NOVARTIS
• NOVAVAX
• OMNINVEST
• PANACEA BIOTEC
• SANOFI-PASTEUR
• SHANGHAI INSTITUTE OF BIOLOGICAL PRODUCTS
• SINOVAC BIOTECH LTD
• SERUM INSTITUTE OF INDIA LTD
• SOLVAY
• ZHEJIANG TIANYUAN BIO-PHARMACEUTICAL CO, LTD
• APPENDIX
• WORLD H1N1 INFLUENZA CASES IN OCTOBER 2009
• COUNTRY WISE DEATH RATES BY H1N1 FLU TILL OCTOBER 2009

LIST OF TABLES

• SUMMARY TABLE GLOBAL MARKET FOR 2009 H1N1 INFLUENZA VACCINE BY PRODUCTS 2009 - 2011 ($MILLIONS)
• TABLE 1 WHO-DEFINED LEVELS OF INFLUENZA PANDEMIC
• TABLE 2 GLOBAL H1N1 2009 INFLUENZA VACCINE MARKET, BY PRODUCTS 2009 - 2011 ($MILLIONS)
• TABLE 3 GLOBAL H1N1 INFLUENZA VACCINE MARKET, BY GEOGRAPHY 2009 - 2011 ($MILLIONS)
• TABLE 4 GLOBAL MARKET FOR INTRAMUSCULAR H1N1 VACCINES, BY GEOGRAPHY 2009 - 2011 ($MILLIONS)
• TABLE 5 GOVERNMENT INTIATIVES FOR H1N1 VACCINE
• TABLE 6 CONTRACTS FOR H1N1 VACCINE
• TABLE 7 MARKET DEVELOPMENT FOR H1N1 VACCINE
• TABLE 8 BENCHMARKING OF VACCINE
• TABLE 9 TECHNOLOGY & DELIVERY OF VACCINE
• TABLE 10 H1N1 VACCINE TRIALS
• TABLE 11 NORTH AMERICAN MARKET FOR H1N1 INFLUENZA VACCINE, 2009 - 2011 ($MILLIONS)
• TABLE 12 ASIA PACIFIC MARKET FOR H1N1 VACCINE, 2009- 2011 ($MILLIONS)

LIST OF FIGURES

• FIGURE 1 PANDEMIC WAVE DIAGRAM - SPANISH INFLUENZA
• FIGURE 2 SPANISH FLU FATALITIES IN THE U.S. (1918-1919)
• FIGURE 3 PANDEMIC SCENARIO OF HONG KONG FLU
• FIGURE 4 PANDEMIC INFLUENZA CYCLE
• FIGURE 5 H1N1 2009 INFLUENZA VACCINE MARKET DYNAMICS
• FIGURE 6 TIER PRICING MODEL FOR H1N1 VACCINE
• FIGURE 7 CONSUMER PERSPECTIVE FOR H1N1 VACCINE MARKET
• FIGURE 8 PRODUCT LIFECYCLE IN H1N1 VACCINE MARKET
• FIGURE 9 RECOMMENDED PRIORITY GROUPS FOR 2009 H1N1 INFLUENZA VACCINE
• FIGURE 10 TIMELINE OF COMMERCIALIZATION OF H1N1 VACCINE
• FIGURE 11 CONTRACT SHARING OF COMPANIES (2009)
• FIGURE 12 GLOBAL SCENARIO OF INFLUENZA PANDEMIC
• FIGURE 13 GLOBAL H1N1 INFLUENZA VACCINE MARKET, BY GEOGRAPHY
• FIGURE 14 MOON MATRIX OF H1N1 VACCINE MARKET, BY GEOGRAPHY